Long Ideas - Ventrus Biosciences (NASDAQ:VTUS) recently hired JP Benya as its new VP of Commercial Operations and Business Development, with the intent that Benya will play a … Continue Reading
Read NowLong Ideas - Celgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast … Continue Reading
Read NowLong Ideas - Major Drug and Diagnostics company, Roche Holdings (OTC:RHBBY) appears to be coming back to the table to take another run at acquiring Illumina (NASDAQ:ILMN), according … Continue Reading
Read NowLong Ideas - By now, the bear story on Questcor Pharmaceuticals (NASDAQ:QCOR) is well understood, with health insurer Aetna (NYSE:AET) indicating that it will make it next-to-impossible to … Continue Reading
Read NowLong Ideas - With Wall Street Analyst price targets on Ariad Pharmaceuticals (NASDAQ:ARIA) averaging $24.75 through this morning, new data for an early-stage pipeline candidate is causing price … Continue Reading
Read NowLong Ideas - By Jake King Merge Healthcare Inc. (NASDAQ:MRGE) could be seeing the first round of corporate bids next week, according to dealReporter. Offers to buy the company, … Continue Reading
Read NowLong Ideas - Exelixis (NASDAQ:EXEL) Thursday is retracing some of its losses from the beginning of the week and is up 10% from yesterday’s close, to $5.00, due … Continue Reading
Read Now